Does IODIPAMIDE MEGLUMINE Cause Off label use? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Off label use have been filed in association with IODIPAMIDE MEGLUMINE. This represents 89.5% of all adverse event reports for IODIPAMIDE MEGLUMINE.
34
Reports of Off label use with IODIPAMIDE MEGLUMINE
89.5%
of all IODIPAMIDE MEGLUMINE reports
34
Deaths
34
Hospitalizations
How Dangerous Is Off label use From IODIPAMIDE MEGLUMINE?
Of the 34 reports, 34 (100.0%) resulted in death, 34 (100.0%) required hospitalization, and 34 (100.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IODIPAMIDE MEGLUMINE. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does IODIPAMIDE MEGLUMINE Cause?
Duodenal ulcer perforation (31)
Hypercholesterolaemia (31)
Blepharospasm (30)
Depression (30)
Epilepsy (30)
Fibromyalgia (30)
Helicobacter infection (30)
Breast cancer stage iii (29)
Dry mouth (29)
Abdominal pain upper (28)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)